Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bergmann

Showing results (221-230 of 254) with videos related to

Pageof 26
Sort By:
Circulation|May 5, 2010
Plasma copeptin and the risk of diabetes mellitusSofia Enhörning, Thomas J Wang, Peter M Nilsson, et al.
JAMA|July 2, 2009
Novel and conventional biomarkers for prediction of incident cardiovascular events in the communityOlle Melander, Christopher Newton-Cheh, Peter Almgren, et al.
European Journal of Heart Failure|March 11, 2010
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failureStephan von Haehling, Gerasimos S Filippatos, Jana Papassotiriou, et al.
European Journal of Heart Failure|September 1, 2019
Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamicsBenjamin Deniau, Linda Rehfeld, Karine Santos, et al.
Journal of the American College of Cardiology|June 27, 2009
Incremental value of copeptin for rapid rule out of acute myocardial infarctionTobias Reichlin, Willibald Hochholzer, Claudia Stelzig, et al.
International Journal of Molecular Sciences|March 25, 2022
Metabolic Response in Endothelial Cells to Catecholamine Stimulation Associated with Increased Vascular PermeabilityAdrián López García de Lomana, Arnar Ingi Vilhjálmsson, Sarah McGarrity, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 5, 2022
Identification of Two Non-Peptidergic Small Molecule Inhibitors of CBX2 Binding to K27 Trimethylated OligonucleosomesLukas Lercher, Nina Simon, Andreas Bergmann, et al.
Plos One|January 26, 2011
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1Ewa A Jankowska, Gerasimos S Filippatos, Stephan von Haehling, et al.
Journal of the American College of Cardiology|November 13, 2007
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failureStephan von Haehling, Ewa A Jankowska, Nils G Morgenthaler, et al.
European Journal of Heart Failure|December 5, 2019
Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmissionPaloma Pandhi, Jozine M Ter Maaten, Johanna E Emmens, et al.
Pageof 26

Showing results (221-230 of 254) with videos related to

Sort By:
Pageof 26
Circulation|May 5, 2010
Plasma copeptin and the risk of diabetes mellitusSofia Enhörning, Thomas J Wang, Peter M Nilsson, et al.
JAMA|July 2, 2009
Novel and conventional biomarkers for prediction of incident cardiovascular events in the communityOlle Melander, Christopher Newton-Cheh, Peter Almgren, et al.
European Journal of Heart Failure|March 11, 2010
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failureStephan von Haehling, Gerasimos S Filippatos, Jana Papassotiriou, et al.
European Journal of Heart Failure|September 1, 2019
Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamicsBenjamin Deniau, Linda Rehfeld, Karine Santos, et al.
Journal of the American College of Cardiology|June 27, 2009
Incremental value of copeptin for rapid rule out of acute myocardial infarctionTobias Reichlin, Willibald Hochholzer, Claudia Stelzig, et al.
International Journal of Molecular Sciences|March 25, 2022
Metabolic Response in Endothelial Cells to Catecholamine Stimulation Associated with Increased Vascular PermeabilityAdrián López García de Lomana, Arnar Ingi Vilhjálmsson, Sarah McGarrity, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 5, 2022
Identification of Two Non-Peptidergic Small Molecule Inhibitors of CBX2 Binding to K27 Trimethylated OligonucleosomesLukas Lercher, Nina Simon, Andreas Bergmann, et al.
Plos One|January 26, 2011
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1Ewa A Jankowska, Gerasimos S Filippatos, Stephan von Haehling, et al.
Journal of the American College of Cardiology|November 13, 2007
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failureStephan von Haehling, Ewa A Jankowska, Nils G Morgenthaler, et al.
European Journal of Heart Failure|December 5, 2019
Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmissionPaloma Pandhi, Jozine M Ter Maaten, Johanna E Emmens, et al.
Pageof 26